Cellectar Biosciences hires Shustov as new Senior Vice President, Medical

Cellectar Biosciences (CLRB) announced that it has hired Andrei Shustov, M.D., as its new Senior Vice President, Medical reporting to James Caruso, president and CEO. In this role, Dr. Shustov will lead and provide oversight on all aspects of the Company’s clinical development program, medical affairs, and medical communications. Dr. Shustov most recently served as Senior Medical Director, Late-Stage Clinical Development at Seagen (SGEN), where he provided clinical expertise and oversight of regulatory submissions and activities of the Global Development Team.